IP Library Granted Patent US 8,163,871
Granted Patent B2
US 8,163,871 · App. 12/284,552 · Granted Apr 24, 2012

Enzymatic reactions in the presence of keto acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,163,871
App. No.
12/284,552
Granted
Apr 24, 2012
Kind
B2
Abstract

Conversion in vitro of X-Gly to X-alpha-hydroxy-Gly or X-NH 2 (X being a peptide or any other compound having a carbonyl group capable of forming a covalent bond with glycine) is accomplished enzymatically in the presence of keto acids, or salts or esters thereof, to provide a good yield without the necessity of catalase or similar enzymatic reaction enhancers. Peptidylglycine α-amidating monooxygenase (PAM) is a preferred enzyme for catalyzing the conversion. Alternatively, peptidylglycine α-hydroxylating monooxygenase (PHM) is utilized to convert X-Gly to X-alpha-hydroxy-Gly which may be recovered, or optionally may be simultaneously or sequentially converted to an amide by either a Lewis base or action of the enzyme peptidyl α-hydroxyglycine α-amidating lyase (PAL). Both PHM and PAL are functional domains of PAM.

Claims (3)

1. An amidated product which has been prepared by reacting a precursor having a glycine residue, in free acid form and attached to a carbonyl group, in the presence of (A) peptidylglycine alpha-amidating monooxygenase and (B) a non-enzymatic reaction-enhancing compound that is an alpha-keto acid, or salt or ester thereof, wherein said alpha-keto acid has the molecular structure RC(O)C(O)OH, and wherein R is selected from the group consisting of aryl, a C1-C4 hydrocarbon moiety, a halogenated or hydroxylated C1-C4 hydrocarbon moiety, and a C1-C4 carboxylic acid, wherein the amidated product has been prepared without catalase or other enzymatic reaction-enhancing compounds.

2. An alpha-hydroxy-glycine product that has been made by the process of reacting a precursor having a glycine residue, in free acid form and attached to a carbonyl group, in the presence of (i) peptidylglycine alpha-hydroxylating monooxygenase and (ii) a non-enzymatic reaction-enhancing compound that is an alpha-keto acid, or salt or ester thereof, wherein said alpha-keto acid has the molecular structure RC(O)C(O)OH, and wherein R is selected from the group consisting of aryl, a C1-C4 hydrocarbon moiety, a halogenated or hydroxylated C1-C4 hydrocarbon moiety, and a C1-C4 carboxylic acid, wherein the alpha-hydroxy glycine product has been prepared without catalase or other enzymatic reaction-enhancing compounds.

3. The product of claim 1 wherein said amidated product is amidated at a location that does not include an amide group in nature.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Jun 28, 2023
From: CADENCE BANK, A MISSISSIPPI BANK AND SUCCESSOR BY MERGER TO CADENCE BANK, N.A., A NATIONAL BANKING ASSOCIATION, AS AGENT
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 064149/0741 →
SECURITY INTEREST Recorded Aug 26, 2019
From: ENTERIS BIOPHARMA, INC.
To: CADENCE BANK, N.A.
Reel/Frame 050174/0428 →
RELEASE OF SECURITY INTEREST Recorded Aug 8, 2019
From: VICTORY PARK MANAGEMENT, LLC
To: UNIGENE LABORATORIES, INC.
Reel/Frame 050000/0796 →
RELEASE OF SECURITY INTEREST Recorded Aug 8, 2019
From: VICTORY PARK MANAGEMENT, LLC
To: UNIGENE LABORATORIES, INC.
Reel/Frame 050000/0799 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2014
From: CONSALVO, ANGELO P.; MEHTA, NOZER M.; STERN, WILLIAM; GILLIGAN, JAMES P.
To: UNIGENE LABORATORIES INC.
Reel/Frame 032434/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2013
From: UNIGENE LABORATORIES, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 030300/0538 →
SECURITY AGREEMENT Recorded Oct 4, 2012
From: UNIGENE LABORATORIES, INC.
To: VICTORY PARK MANAGEMENT, LLC, AS COLLATERAL AGENT
Reel/Frame 029074/0689 →
SECURITY AGREEMENT Recorded May 22, 2009
From: UNIGENE LABORATORIES, INC.
To: VICTORY PARK MANAGEMENT, LLC
Reel/Frame 022728/0506 →